<DOC>
	<DOC>NCT01614002</DOC>
	<brief_summary>The main purpose of this observational study with Docetaxel is to determine the number of treatment cycles and the quantity of Doce onkovis needed therefore under the special circumstance of ambulant chemotherapy. onkovis aims an economical utilization of the chemotherapeutics.The provision with adapted packaging sizes as to decrease the excess quantity to be discarded follows also this objective. Secondary objectives are the evaluation of the safety and tolerability of Doce onkovis. To this purpose data regarding co medications and adverse events are also collected.</brief_summary>
	<brief_title>A Non Interventional Study With Doce Onkovis (Docetaxel) Utilized for the Treatment of Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>Indication for Docetaxel according to the SmPC and treating physician according to the Docetaxel SmPC</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>carcinoma</keyword>
	<keyword>breast cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>prostata cancer</keyword>
	<keyword>adenocarcinoma of the stomach</keyword>
	<keyword>squamous cell carcinoma of the head and neck region</keyword>
	<keyword>ambulant chemotherapy</keyword>
	<keyword>treatment cycles</keyword>
	<keyword>Docetaxel</keyword>
	<keyword>Doce onkovis</keyword>
	<keyword>Quantity of Docetaxel</keyword>
	<keyword>Packaging Sizes</keyword>
</DOC>